(Q37785406)

23 August 2017

1 reference

title

Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS. (English)

1 reference

23 August 2017

0 references

1

Vitetta ES

1 reference

23 August 2017

publication date

1 November 1990

1 reference

Journal of Clinical Immunology

23 August 2017

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

6 Suppl

1 reference

23 August 2017

page(s)

15S-18S

1 reference

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

23 August 2017

cites work

1 reference

12 December 2020

Purification of ricin A1, A2, and B chains and characterization of their toxicity.

1 reference

12 December 2020

The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies

1 reference

12 December 2020

Antibody toxin conjugates: a perspective

1 reference

12 December 2020

Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry

1 reference

12 December 2020

HIV infection is blocked in vitro by recombinant soluble CD4.

1 reference

12 December 2020

Evaluation of ricin A-chain immunotoxins directed against human T cells

1 reference

12 December 2020

An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins

1 reference

12 December 2020

In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain

1 reference

12 December 2020

Therapeutic strategies with monoclonal antibodies and immunoconjugates

1 reference

12 December 2020

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

1 reference

12 December 2020

New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo.

1 reference

12 December 2020

Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin

1 reference

12 December 2020

Activity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxin

1 reference

12 December 2020

The human immunodeficiency virus: infectivity and mechanisms of pathogenesis

1 reference

12 December 2020

HIV-infected cells are killed by rCD4-ricin A chain

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Improved antitumor effects of immunotoxins prepared with deglycosylated ricin A-chain and hindered disulfide linkages

1 reference

12 December 2020

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

1 reference

12 December 2020

1 reference

12 December 2020

Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins

1 reference

12 December 2020

Cloning and expression of recombinant, functional ricin B chain

1 reference

12 December 2020

Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization

1 reference

12 December 2020

Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution

1 reference

12 December 2020

Nucleotide sequence of cloned cDNA coding for preproricin

1 reference

12 December 2020

Epidemiology of HIV infection and AIDS in the United States

1 reference

12 December 2020

Redesigning nature's poisons to create anti-tumor reagents

1 reference

12 December 2020

Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein

1 reference

12 December 2020

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

1 reference

12 December 2020

Immunotoxins: A New Approach to Cancer Therapy

1 reference

12 December 2020

Endocytosis of a monoclonal antibody recognising a cell surface glycoprotein antigen visualised using fluorescent conjugates

1 reference

12 December 2020

In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins

1 reference

12 December 2020

Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats

1 reference

12 December 2020

Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain

1 reference

12 December 2020

Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein

1 reference

12 December 2020

Expression of ricin A chain in Escherichia coli

1 reference

12 December 2020

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00918687

1 reference

23 August 2017

1 reference